| NCT ID | NCT07452562 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Swansea University |
| Condition | Multiple Sclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-07 |
| Primary Completion | 2027-01-18 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress. Participants will be randomly assigned to receive either 500mg of Hesperidin or a matching placebo daily for 12 weeks. The primary outcome is fatigue, with secondary outcomes including cognitive performance and mood. The trial seeks to determine if this dietary intervention offers symptom-alleviating benefits.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Multiple Sclerosis, Aged 18 years or older. Exclusion Criteria: * Known food allergies, intolerances, or significant gastrointestinal (GI) problems, Participants under the age of 18 years.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.